Edition:
India

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

20.67USD
19 Jun 2019
Change (% chg)

-- (--)
Prev Close
$20.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
250,038
52-wk High
$21.16
52-wk Low
$8.34

About

Coherus BioSciences, Inc. is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Company's business is organized around therapeutic franchises, including Oncology biosimilar candidates pegfilgrastim (Neulasta) and bevacizumab... (more)

Overall

Beta: --
Market Cap(Mil.): $695.75
Shares Outstanding(Mil.): 51.35
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates